Oxford Biomedica and VMIC announce collaboration
The five-year deal will see the parties work collaboratively to facilitate the manufacture of viral vector based vaccines
Read More
Tag: Oxbox
Oxford Biomedica bags MHRA nod for two manufacturing suites
The move will provide access to the Oxford COVID-19 Vaccine Consortium for production of vaccine should trials prove successful
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
